Chung Ming-Ting, Tsai Yung-Chieh, Chen Sheng-Hsien, Loo Tao-Chuan, Tang Hsun-Han, Lin Liang-Yin
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Chimei Medical Center, Yung-Kang City, Tainan, Taiwan.
J Assist Reprod Genet. 2006 Jul-Aug;23(7-8):343-6. doi: 10.1007/s10815-006-9056-y. Epub 2006 Aug 16.
To compare the clinical outcome of IVF treatment after pituitary suppression with two different oral contraceptives (OCs).
65 patients who received IVF treatment was classified into 2 groups based on the difference of OCs they used for pituitary suppression before ovarian hyperstimulation. Group 1 included 36 patients who received monophasic OCs. Group 2 included 29 patients who received triphastic OCs. Both groups received the OCs from the 5th day of the cycle for consecutive 21 days. The hormone profiles after OCs and clinical outcome of IVF treatment were compared between two groups. Two-sample t-tests and X2 tests were used for statistical analyses. P < 0.05 was considered statistically significant.
The mean age and basal hormone profiles were comparable between two groups. After ovulation suppression with different OCs, the day 2 FSH and LH value revealed statistically significant difference between two groups(4.2+/-1.8 vs 6.0+/-2.6; 2.7+/-2.0 vs 4.2+/-3.3 respectively). The numbers of oocyte per retrieval and fertilization rate were comparable between two groups, but higher quality embryos as revealed by the cleavage speed were noted in the triphastic OCs group. Although statistically not significant, higher implantation rate and pregnancy rate were also noted in the triphastic OCs group.
Different OCs for pituitary suppression can result in different hormone profiles. Ovulation induction in IVF treatment should be individualized according to these hormone changes to achieve the optimal clinical outcome. Triphastic OCs exceeds monophastic OCs in producing good quality embryo in IVF-ET treatment.
比较使用两种不同口服避孕药(OCs)抑制垂体后进行体外受精(IVF)治疗的临床结局。
65例接受IVF治疗的患者根据卵巢过度刺激前用于抑制垂体的OCs差异分为2组。第1组包括36例接受单相OCs的患者。第2组包括29例接受三相OCs的患者。两组均在月经周期的第5天开始连续21天服用OCs。比较两组服用OCs后的激素水平及IVF治疗的临床结局。采用两样本t检验和X²检验进行统计学分析。P<0.05被认为具有统计学意义。
两组的平均年龄和基础激素水平相当。使用不同的OCs抑制排卵后,两组第2天的促卵泡生成素(FSH)和促黄体生成素(LH)值有统计学显著差异(分别为4.2±1.8 vs 6.0±2.6;2.7±2.0 vs 4.2±3.3)。两组每次取卵的卵母细胞数量和受精率相当,但三相OCs组的胚胎分裂速度显示胚胎质量更高。虽然无统计学显著差异,但三相OCs组的种植率和妊娠率也较高。
不同的OCs用于抑制垂体可导致不同的激素水平。IVF治疗中的排卵诱导应根据这些激素变化进行个体化,以实现最佳临床结局。在IVF-ET治疗中,三相OCs在产生高质量胚胎方面优于单相OCs。